These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20473867)

  • 1. Tasmanian devil facial tumor disease: insights into reduced tumor surveillance from an unusual malignancy.
    O'Neill ID
    Int J Cancer; 2010 Oct; 127(7):1637-42. PubMed ID: 20473867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis and molecular biology of a transmissible tumor in the Tasmanian devil.
    Bender HS; Marshall Graves JA; Deakin JE
    Annu Rev Anim Biosci; 2014 Feb; 2():165-87. PubMed ID: 25384139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology of a Transmissible Cancer Spreading among Tasmanian Devils.
    Woods GM; Howson LJ; Brown GK; Tovar C; Kreiss A; Corcoran LM; Lyons AB
    J Immunol; 2015 Jul; 195(1):23-9. PubMed ID: 26092814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biting injuries and transmission of Tasmanian devil facial tumour disease.
    Hamede RK; McCallum H; Jones M
    J Anim Ecol; 2013 Jan; 82(1):182-90. PubMed ID: 22943286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Decades of the Impact of Tasmanian Devil Facial Tumor Disease.
    Woods GM; Fox S; Flies AS; Tovar CD; Jones M; Hamede R; Pemberton D; Lyons AB; Bettiol SS
    Integr Comp Biol; 2018 Dec; 58(6):1043-1054. PubMed ID: 30252058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise review: transmissible animal tumors as models of the cancer stem-cell process.
    O'Neill ID
    Stem Cells; 2011 Dec; 29(12):1909-14. PubMed ID: 21956952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Devil Facial Tumor Disease.
    Pye RJ; Woods GM; Kreiss A
    Vet Pathol; 2016 Jul; 53(4):726-36. PubMed ID: 26657222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative genomics approach to understanding transmissible cancer in Tasmanian devils.
    Deakin JE; Belov K
    Annu Rev Genomics Hum Genet; 2012; 13():207-22. PubMed ID: 22657390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population.
    Pearse AM; Swift K; Hodson P; Hua B; McCallum H; Pyecroft S; Taylor R; Eldridge MD; Belov K
    Cancer Genet; 2012 Mar; 205(3):101-12. PubMed ID: 22469509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trophic cascades following the disease-induced decline of an apex predator, the Tasmanian devil.
    Hollings T; Jones M; Mooney N; McCallum H
    Conserv Biol; 2014 Feb; 28(1):63-75. PubMed ID: 24024987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A murine xenograft model for a transmissible cancer in Tasmanian devils.
    Kreiss A; Tovar C; Obendorf DL; Dun K; Woods GM
    Vet Pathol; 2011 Mar; 48(2):475-81. PubMed ID: 20861503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
    Tovar C; Patchett AL; Kim V; Wilson R; Darby J; Lyons AB; Woods GM
    PLoS One; 2018; 13(4):e0196469. PubMed ID: 29702669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
    Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
    Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmissible cancer in Tasmanian devils: localized lineage replacement and host population response.
    Hamede RK; Pearse AM; Swift K; Barmuta LA; Murchison EP; Jones ME
    Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26336167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
    Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
    Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific diagnostic marker for transmissible facial tumors of Tasmanian devils: immunohistochemistry studies.
    Tovar C; Obendorf D; Murchison EP; Papenfuss AT; Kreiss A; Woods GM
    Vet Pathol; 2011 Nov; 48(6):1195-203. PubMed ID: 21383118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunohistochemical characterization of devil facial tumor disease (DFTD) in the Tasmanian Devil (Sarcophilus harrisii).
    Loh R; Hayes D; Mahjoor A; O'Hara A; Pyecroft S; Raidal S
    Vet Pathol; 2006 Nov; 43(6):896-903. PubMed ID: 17099146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.
    Brown GK; Tovar C; Cooray AA; Kreiss A; Darby J; Murphy JM; Corcoran LM; Bettiol SS; Lyons AB; Woods GM
    Immunol Cell Biol; 2016 Aug; 94(7):673-9. PubMed ID: 27089941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex determination by SRY PCR and sequencing of Tasmanian devil facial tumour cell lines reveals non-allograft transmission.
    Cui X; Wang Y; Hua B; Miller W; Zhao Y; Cui H; Kong X
    Biochem Biophys Res Commun; 2016 May; 474(1):29-34. PubMed ID: 27084454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced effect of Tasmanian devil facial tumor disease at the disease front.
    Hamede R; Lachish S; Belov K; Woods G; Kreiss A; Pearse AM; Lazenby B; Jones M; McCallum H
    Conserv Biol; 2012 Feb; 26(1):124-34. PubMed ID: 21978020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.